GLP-1 (Semaglutide)
Reported Onset
1–4 weeks (appetite suppression), 4–12 weeks (weight loss)
Primary Use
Significant weight loss via appetite suppression and metabolic improvement.
Dose
0.25mg - 2.4mg
Frequency
Weekly
GLP-2
Reported Onset
2–4 weeks
Primary Use
Gut health restoration, intestinal repair, and nutrient absorption optimization.
Dose
50mcg - 100mcg
Frequency
Daily
Community Verdict
GLP-1 vs GLP-2 — appetite suppression vs gut repair. The community generally selects between GLP-1 (Semaglutide) and GLP-2 based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for GLP-1 (Semaglutide) or GLP-2 at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified